Pfizer’s PFE stock has declined 7.8% in the past month. Though the stock has been affected by declining sales of its COVID ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

All of the shares of common stock are being offered by Revolution Medicines. In addition, Revolution Medicines intends to grant the underwriters a 30-day option to pur REDWOOD CITY, Calif., ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Revolution Medicines (RVMD) announced that it has commenced an underwritten public offering to sell up to $600M of shares of its common stock. All of the shares of common stock are being offered ...

JP Morgan initiates coverage on Blueprint Medicines, highlighting Ayvakit's significant growth, 2024 revenue forecast, and potential strategic opportunities. Vandana Singh C.H. Robinson Worldwide ...

Amid a rise in contagious diseases across Karnataka, a shortage of life-saving drugs is causing concern. Over 250 essential ...